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Abstract
Introduction
Colorectal cancer (CRC) screening rates are low in New 
Mexico. We used statewide surveys of primary care phy-
sicians and the general population to characterize CRC 
screening practices and compare perceptions about screen-
ing barriers.
Methods
In  2006,  we  surveyed  714  primary  care  physicians  in 
New Mexico about their CRC screening practices, beliefs, 
and  perceptions  of  patient,  provider,  and  system  barri-
ers. A 2004 state-specific CRC screening module for the 
Behavioral Risk Factor Surveillance System (BRFSS) sur-
vey asked 3,355 participants aged 50 years or older why 
they had not ever or had not recently completed a fecal 
occult blood test (FOBT) or lower endoscopy.
Results
The 216 physicians (30% response rate) reported offering 
screening to a median 80% of their average-risk patients 
in the past year and estimated that a median 50% were 
current  with  screening.  They  attributed  low  screening 
proportions  mainly  to  patient  factors  (embarrassment, 
fear of pain, lack of insurance). However, just 51% of phy-
sician respondents used health maintenance flow sheets, 
and only 13% used electronic medical records to identify 
patients due for CRC screening. The BRFSS respondents 
most often reported that lack of physician discussion was 
responsible  for  not  being  current  with  screening  (45% 
FOBT,  34%  endoscopy);  being  asymptomatic  was  also 
often cited as an explanation for lack of screening (22% 
FOBT, 36% endoscopy).
Conclusion
Physicians and adults in the general population had mark-
edly different perspectives on barriers to CRC screening. 
Increasing screening may require system supports to help 
physicians readily identify patients due for CRC testing 
and interventions to educate patients about the rationale 
for screening.
Introduction
Colorectal cancer (CRC) is the fourth most frequently diag-
nosed cancer in New Mexico and the second leading cause 
of cancer death (1). In 2009, an estimated 800 new CRC 
cases were diagnosed in New Mexico, and approximately 
300 people died from this disease. Although CRC screen-
ing reduces both CRC incidence and mortality (2-4), just 
over half of New Mexican adults aged 50 years or older 
are considered current with screening (5). Consequently, 
fewer than half of the cancers in New Mexico are being 
diagnosed at an early stage, when they can be most effec-
tively treated (6).
In New Mexico, the Clinical Prevention Initiative, a state-
wide partnership of health care organizations supported 
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by the New Mexico Department of Health and the Centers 
for Disease Control and Prevention (CDC) (7), works to 
increase the delivery of high-impact preventive services 
(8) by targeting primary care providers. To guide inter-
ventions,  the  Clinical  Prevention  Initiative  CRC  work-
group decided to survey primary care providers to assess 
perceived barriers to CRC screening. The Department of 
Health had also recently collected population-based data 
on  screening  barriers  through  CDC’s  Behavioral  Risk 
Factor Surveillance System (BRFSS) survey.
Although  numerous  barriers  and  facilitators  to  CRC 
screening  have  been  identified  in  the  literature  (9-14), 
including patient, provider, health system, and policy fac-
tors, few surveys have been able to compare contempora-
neous responses from providers and a general population 
(15). Furthermore, many studies were conducted before 
Medicare began reimbursing for screening colonoscopy in 
2001 and before the 2002 publication of US Preventive 
Services Task Force (USPSTF) guidelines strongly recom-
mending CRC screening (16), which substantially altered 
screening  practices  (5,17).  Results  from  other  states  or 
regions may not necessarily be applicable in New Mexico; 
a lower proportion of New Mexicans is screened for CRC 
compared  with  national  averages  (54.8%  vs  57.3%)  (5). 
Additionally, national data show declining CRC incidence 
from  1997  through  2006  for  both  sexes  and  all  major 
racial/ethnic  groups  (18);  however,  incidence  in  New 
Mexico  has  been  stable  or  increasing  among  Hispanics 
and American Indians (6). New Mexico is the fifth larg-
est state but only the 36th most populated state and has 
substantially higher than national population percentages 
of Hispanics (45% vs 15%) and American Indians (10% vs 
1%) (19). Given New Mexico’s anomalous trends in CRC 
incidence and diverse minority populations, the primary 
objective of our study was to comprehensively characterize 
provider-reported practices and barriers for CRC screen-
ing. A secondary objective was to compare these provider 
perceptions with those of the general population.
Methods
Physician survey
A  team  of  content  and  methodology  experts  at  the 
University of New Mexico Cancer Center developed the 
primary care physician survey in 2005. Some items were 
adapted from a National Cancer Institute survey on CRC 
screening barriers (15). We revised the survey after pilot 
testing it with a sample of 5 primary care physicians who 
assessed content and face validity. The final 34-item sur-
vey was divided into 6 sections that addressed the practice 
strategies and system support for performing screening 
(patient  education,  reminders,  tracking),  the  rationale 
for  recommending  screening  (influential  factors),  cancer 
screening  beliefs  and  practices  (perceived  effectiveness, 
testing  recommendations,  patient  adherence),  screening 
barriers  (patient,  provider,  system),  practice  character-
istics (type, location, size), and physician characteristics 
(demographics, specialty). (Readers can obtain a copy of 
the  survey  from  the  corresponding  author.)  Screening 
practice items were based on USPSTF recommendations 
(16) for average-risk patients aged 50 years or older and 
included  the  options  of  colonoscopy,  flexible  sigmoidos-
copy, barium enema, or fecal occult blood testing (FOBT). 
We used 6-point rating scales ranging from “never”/“not” 
= 1 to “most”/“very” = 6 to measure survey items assess-
ing screening beliefs, practices, and barriers. The human 
research  review  committee  of  the  University  of  New 
Mexico approved the physician survey.
We identified potential respondents from the 2006 New 
Mexico Board of Medical Examiners provider list, which 
contains the self-identified specialties and addresses for 
licensed physicians in New Mexico. The eligibility criterion 
was a primary specialty listing of internal medicine, fam-
ily medicine, general practice, or geriatrics. We excluded 
physicians with secondary specialties that indicated that 
they were not primary care providers, including medical 
subspecialties, urgent care, or administration.
We  mailed  964  surveys  in  June  2006  accompanied  by 
a cover letter signed by leaders of primary care profes-
sional organizations and the New Mexico Department of 
Health. We subsequently mailed surveys approximately 
3 and 5 months later to nonrespondents. We did not offer 
compensation for participating in the survey. On the basis 
of  returned  mailings,  updated  Medical  Examiners  lists, 
and survey responses, we excluded 123 physicians from 
our denominator because we could not locate them and 
another 127 physicians who either were no longer licensed 
in New Mexico (retired or moved) or who were not primary 
care providers. We were left with a denominator of 714 
respondents and 216 completed surveys, for a response 
rate of 30%.
Population-based survey
The study participants were a population-based sample of VOLUME 8: NO. 2
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respondents to the 2004 New Mexico BRFSS, a federally 
funded annual survey implemented in collaboration with 
state health departments. Random-digit dialing methods 
were used to derive a probability sample of households 
with telephones to collect data on health-related behaviors 
and risk factors for respondents aged 18 years or older. 
In 2004, the New Mexico Department of Health designed 
a  module  that  was  administered  to  6,390  adults  aged 
50 years or older that asked about CRC screening with 
a home FOBT and lower endoscopy. Overall, 3,355 par-
ticipants who reported being not current or never tested 
with either home FOBT or lower endoscopy were asked to 
provide the most important reason for the lack of testing. 
These  participants  included  1,695  who  had  never  per-
formed a home FOBT and 798 who had not been tested in 
the past year, as well as 1,504 who never had undergone 
a sigmoidoscopy or colonoscopy and 297 who had not been 
tested in the past 5 years.
Statistical analyses
For the physician survey, we used descriptive statistics to 
characterize providers, practices, screening practices, and 
ratings of barriers to screening. We conducted a series of 
exploratory factor analyses on the patient, provider, and 
system barriers assessed by the survey to confirm that 
survey items clustered within these 3 distinct groups of 
barriers.  We  used  factorial  within-subjects  multivariate 
analyses of variance to directly compare physician rating 
levels within each set of barriers to CRC screening (20).
To account for the complex survey design of the BRFSS, 
we used Stata 9.0 (StataCorp LP, College Station, Texas) 
to estimate percentages and their 95% confidence inter-
vals (CIs) by demographic characteristics. All estimates 
represent  weighted  population-based  estimates  for  resi-
dents aged 50 years or older who responded to the 2004 
New Mexico BRFSS.
Results
Physician survey
Among  the  physician  respondents  who  completed  these 
survey  items,  most  were  middle-aged  white  men  who 
practiced in urban areas (Table 1). Almost half practiced 
in physician-owned, single-specialty practices, and most 
worked in small groups.
Few practices used an electronic medical record to identify 
patients due for CRC screening and most did not have a 
mechanism to ensure that patients completed FOBT tests 
(Table 2). However, few respondents found it difficult to 
arrange CRC screening.
The  most  influential  factors  for  screening,  on  a  6-point 
scale from 1 (not at all influential) to 6 (very influential), 
were evidence from the medical literature and professional 
guidelines. Respondents considered screening colonoscopy 
to be the most effective strategy for reducing CRC mor-
tality. They were less enthusiastic about FOBT, flexible 
sigmoidoscopy, and barium enema.
Colonoscopy was recommended at least some of the time 
for  screening  average-risk  patients  by  94%  of  respon-
dents  compared  with  86%  for  FOBT.  Overall,  74%  of 
respondents  never  recommended  flexible  sigmoidoscopy, 
and 74% never recommended barium enema. Nearly all 
respondents reported that they began screening average-
risk patients at age 50 for each of the screening procedures 
except  FOBT,  for  which  23%  reported  that  they  began 
screening patients in their 40s. The mean (standard devia-
tion) screening interval in years was 1.4 (1.6) for FOBT, 
8.2 (2.6) for colonoscopy, 6.3 (2.4) for barium enema, and 
4.5 (1.3) for flexible sigmoidoscopy. Nearly all respondents 
indicated that they had an upper age limit for screening 
with  colonoscopy,  barium  enema,  and  flexible  sigmoid-
oscopy; about half indicated that they would not screen 
beyond age 80. However, 63% of respondents reported not 
having an upper age limit for FOBT screening.
In  the  past  year,  respondents  estimated  offering  CRC 
screening  to  a  median  (interquartile  range)  80%  (70%-
95%)  of  their  patients  aged  50  years  or  older.  Overall, 
respondents estimated that 50% (40%-70%) of their eli-
gible patients were current with CRC screening recom-
mendations.
Only 3 patient barriers were rated 4 or higher on the 6-
point rating scale: embarrassment/anxiety, fear of pain, 
and inadequate insurance (Table 3). Physician barriers 
were all rated below the midpoint of 3.5 on the 6-point 
rating scale, indicating that physicians did not see them-
selves as often creating barriers to screening. Similarly, 
physicians  generally  did  not  perceive  system  factors, 
which  were  categorized  into  implementing  screening 
and obtaining lower endoscopy, as creating barriers to 
screening.VOLUME 8: NO. 2
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Population-based survey
Among  the  3,355  respondents  to  the  BRFSS  module 
questions about lack of screening, 58% were aged 50 to 
64 years, 47% were men, 67% were non-Hispanic whites, 
and 26% were Hispanic. By far, the most frequently cited 
response for never having undergone CRC screening or 
not being current with either FOBT or lower endoscopy 
was  that  a  doctor  never  suggested  testing  (Table  4).  A 
substantial proportion of participants indicated that lack 
of symptoms was the reason for not being screened. Few 
reported testing being distasteful or embarrassing, hav-
ing fear of cancer, or having fear of pain with testing as 
barriers.  Furthermore,  access  and  cost  issues  were  not 
frequently listed as barriers for FOBT, though they were 
slightly more common for endoscopic procedures.
Discussion
We  found  that  physicians  and  patients  had  markedly 
different  perspectives  on  barriers  to  CRC  screening. 
Although physicians reported offering screening to most 
of their average-risk patients, they acknowledged limited 
adherence. Physicians most often cited patient factors as 
being frequent barriers, including fear of pain, embarrass-
ment and anxiety about testing, lack of insurance, and 
lack of knowledge about cancer and screening. Meanwhile, 
population-based data from adults aged 50 years or older 
showed that they rarely considered discomfort or embar-
rassment to be a primary barrier. Respondents were far 
more likely to report that lack of a physician recommen-
dation or lack of symptoms prevented them from getting 
tested.
Other investigators have also noted a discrepancy between 
physician  and  patient  perspectives  on  barriers,  though 
not at a statewide level. Klabunde and colleagues com-
pared  results  from  nearly  concurrent  national  surveys 
of  providers  (1999-2000  Survey  of  Colorectal  Cancer 
Screening Practices) and adults in the general population 
(2000  National  Health  Interview  Survey  [NHIS])  (15). 
Investigators asked a nationally representative sample of 
primary care providers to rate the importance of patient 
and health care system barriers to screening with either 
FOBT or lower endoscopy. More than 90% of the physi-
cian respondents identified at least 1 major barrier, more 
often  patient-related  (80%)  than  system-related  (68%). 
The most frequently cited patient barriers were embar-
rassment/anxiety about testing (56%), lack of awareness 
of screening/not perceiving the seriousness of CRC (48%), 
and  fear  of  finding  cancer  (28%).  The  most  frequently 
cited system barrier was financial (46%). In contrast, only 
1% of NHIS respondents reported concerns about pain or 
embarrassment  as  major  barriers  for  lower  endoscopy. 
The most frequently cited barriers by patients were not 
seeing a need for testing/lack of awareness (51%), which 
was concordant with the physicians’ responses; however, 
21% also reported that their doctor did not order or recom-
mend the test.
Physicians’  failure  to  discuss  screening  is  a  common 
theme in patient surveys. Even though lack of time to dis-
cuss screening was not seen as a frequent barrier by our 
respondents,  the  literature  suggests  otherwise.  Yarnall 
and  colleagues  estimated  that  it  would  take  7.4  hours 
a  day  for  a  provider  in  an  adult  primary  care  practice 
to  address  the  preventive  services  deemed  effective  by 
USPSTF  (21).  Competing  health  demands  can  make  it 
difficult to address screening during routine office visits, 
and a meta-analysis found that conducting a prevention 
visit was significantly associated with being able to deliver 
more screening (22).
Additionally, only one-third of our respondents reported 
that their practice had written policies for CRC screening, 
and availability of tracking systems and electronic medical 
records was limited. This may be an unrecognized provider 
barrier to discussing screening. Inadequate use of office 
systems has been identified as a major barrier for achiev-
ing screening (23,24). Developing office policies is seen as 
a  necessary  first  step  to  ensuring  system  changes  (25), 
and employing a tracking system can facilitate effective 
screening by identifying patients who are due for screen-
ing (or surveillance) — and ensuring that results of screen-
ing and diagnostic tests are documented (24).
Physician-patient  communication  about  CRC  screening 
may be less than ideal. Our results suggest that physi-
cians may not be fully aware of patients’ attitudes and 
values  toward  screening.  Ling  and  colleagues  studied 
attitudes  toward  CRC  screening  among  physicians  and 
patients  at  a  single  academic  practice  (26).  Physicians 
markedly overestimated test discomfort as a barrier com-
pared with patients and underestimated the importance 
of test accuracy for patients. Physicians may also not rec-
ognize the importance of helping patients make informed 
decisions for screening. CRC screening is a complex issue 
because multiple testing options are available, and various 
criteria are used to assess risks (27,28). These concepts VOLUME 8: NO. 2
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can be difficult to convey, and the literature suggests that 
discussions often do not take place (29) or are inadequate 
(30,31). One study analyzed audiotaped clinic visits and 
found that although 40% of discussions provided patients 
with background information about screening, most did 
not  address  alternatives  (74%)  or  pros  and  cons  (83%), 
or elicit patient preferences (83%). Conversely, providing 
patients with a CRC screening decision aid that informed 
them  about  cancer  risks  and  available  effective  tests 
was associated with a significant increase in completing 
screening tests (32).
The physician survey responses also revealed some implic-
it  barriers  to  effective  screening.  Physicians  believed 
that colonoscopy was more effective than FOBT and flex-
ible sigmoidoscopy. This finding mirrors national survey 
results (33) and may be attributed to guidelines that rate 
colonoscopy as the optimal test (34). However, the objective 
evidence for screening effectiveness for FOBT is based on 
randomized controlled trials (2), whereas only case-control 
and observational data support the effectiveness of colo-
noscopy (35-37). Consequently, USPSTF gives an overall 
“A” rating to CRC screening, without recommending any 
specific tests (27). In New Mexico, capacity for colonoscopy 
is limited (38), suggesting that using alternative tests may 
be necessary to achieve higher screening rates.
Another issue was the potential for overscreening elderly 
patients. Among respondents to the questions about stop-
ping screening, 63% did not indicate any upper age for 
stopping FOBT, while 55% of those who set an upper age 
for colonoscopy would continue recommending screening 
past age 80. USPSTF recommends that screening not be 
offered for patients aged 85 years or older and offered only 
after a risk-benefit discussion with patients aged 76 to 84 
years because patients with limited life expectancy have 
little expected benefit from screening (27). Other provider 
surveys have also indicated insufficient consideration of 
patient  age  when  making  screening  recommendations 
(39,40). Although the FOBT is inexpensive and safe, false-
positive results are common and abnormal studies require 
diagnostic colonoscopy. Screening patients who are unlike-
ly to receive any benefit is an inefficient use of resources.
Limitations
Our  study  had  some  potential  limitations.  The  overall 
response  rate  to  the  physician  survey  was  low,  creat-
ing  a  potential  selection  bias  if  respondents  were  not 
representative of the population of New Mexico primary 
care physicians. However, a recent New Mexico Health 
Policy  Commission  (NMHPC)  report  suggests  that  the 
demographics of our sample were consistent with state-
wide data on primary care physicians (41). In 2008, the 
NMHPC  reported  that  43%  of  primary  care  physicians 
were aged 55 or older (vs 39% in our sample), 56.9% were 
men  (vs  68%),  and  48%  were  in  the  county  containing 
Albuquerque  (vs  47%).  We  also  know  that  our  denomi-
nator of potentially eligible physicians was not accurate 
and that we likely underestimated our response rate. We 
relied on the Board of Medical Examiners physician list-
ings, which do not consistently characterize specialty or 
training status, so we may have misclassified specialists 
and trainees as being primary care physicians. Contact 
information is updated only every 3 years, so we could not 
be certain that we had correct addresses. However, our 
results in terms of practice patterns, system support, and 
barriers are consistent with those of other surveys report-
ing higher response rates (15,33). We were also unable to 
verify  provider  responses  regarding  screening  practices 
and adherence.
The BRFSS data are subject to selection and recall bias, 
although  reports  of  physicians  failing  to  recommend 
screening are supported by national surveys (15) as well 
as directly observed patient encounters (31). Social desir-
ability bias may have caused respondents to minimize fear 
and  embarrassment  as  screening  barriers.  Finally,  our 
data are ecologic; physician and BRFSS respondents are 
not directly linked, which could result in differing percep-
tions of barriers, particularly related to access.
Conclusion
Our results suggest that CRC screening in New Mexico 
could be facilitated by information systems that readily 
identify patients who are due for screening and track test 
results. Physicians may also increase screening by educat-
ing patients about cancer and the rationale and options for 
screening. Physicians in a state with limited resources for 
cancer screening should also avoid potentially inefficient 
(not having an upper age limit for FOBT screening) and 
impractical  (emphasizing  screening  colonoscopy)  screen-
ing strategies.
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Tables
Table 1. Physician Demographic and Practice Characteristics, New Mexico Primary Care Physician Survey of Colorectal Cancer 
Screening Barriers (N = 216), 2006
Characteristic
Mean (SD) 
or %
Age, y (n = 153) 0. (9.9)
Male sex (n = 152) 8%
Race (n = 121)
White 9%
Other %
Hispanic or Latino ethnicity (n = 149) 9%
Years since graduating medical school (n = 153) 2 (10.)
Specialty (n = 205)
Internal medicine %
Family medicine %
General practice %
Missing %
Have a subspecialty (n = 216) 11%
Have a medical school faculty appointment (n = 155) 0%
Personally perform flexible sigmoidoscopy (n = 202) 19%
Proportion of outpatients aged ≥50 y (n = 189) 1 (.9)
Practice site (n = 172)
Albuquerque (metro population >800,000) %
Other urban excluding Albuquerque (metro population 
>0,000)
1%
Small town or rural 8%
Characteristic
Mean (SD) 
or %
Practice setting (n = 170)
Physician-owned %
Group or staff model health maintenance organization 1%
Community health center 1%
University 12%
Public health/Indian Health Service 8%
Private hospital or clinic %
Veterans Affairs/military %
No. of physicians in practice setting (n = 172)
1 1%
2- %
-10 21%
≥11 1%
Works in multispecialty practice (n = 175) %
No. of outpatients seen weekly (n = 175)  (.)
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Table 2. Practice Strategies and System Support for Performing Colorectal Cancer Screening, New Mexico Primary Care Physician 
Survey of Colorectal Cancer Screening Barriers (N = 216), 2006
Strategy/Support %
How CRC screening education is provided (n = 216a)
Providers discuss screening 9
Staff discuss screening 21
Posters/brochures in the waiting room 19
Brochures handed to patients 12
Letters to patients 
Electronic media 2
Other 1
None 1
Practice has an electronic medical record (n = 216) 
Ways provider identifies patients due for CRC screening (n = 216a)
Asking patient at clinic visit 
Health maintenance flow sheetb 1
Progress notec 
Electronic medical record 1
Do not identify 
Chart tickler 
Other 
Has method to track that patients complete and return FOBT tests  
(n = 208)
Yes 18
No 
Does not order FOBT 8
Has mechanism to ensure FOBT results are in the medical 
record (n = 193)
80
Has written policies or protocols for CRC screening (n = 205) 
Patient notified about screening or diagnostic test results 
(n = 203)
8
Strategy/Support %
Ways provider finds out about colorectal endoscopic results (n = 215a)
Mail 
Medical record review 9
Electronic communication 1
Other 9
Ways provider finds out about colorectal radiological procedure results 
(n = 207a)
Mail 
Medical record review 8
Electronic communication 21
Telephone 
Other 8
Provider notifies patient about screening or diagnostic test 
results (n = 203)
8
Ways provider notifies patients about test results (n = 174a)
In person 
Mail 0
Telephone 
Electronic 
Perceived difficulty in arranging CRC screening (n = 202)
Not at all difficult or low difficulty 0
Moderately difficult 2
Very difficult 1
 
Abbreviations: CRC, colorectal cancer; FOBT, fecal occult blood test. 
a Percentages do not total 100 because providers could select more than 1 
response. 
b Defined as a tracking system to remind health care providers when 
patients are due for various preventive services. 
c Defined as documentation in the medical record of the issues addressed in 
a clinic visit.VOLUME 8: NO. 2
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Table 3. Physician Ratings of Patient, Provider, and System Barriers to Colorectal Cancer Screening, New Mexico Primary Care 
Physician Survey of Colorectal Cancer Screening Barriers (N = 216), 2006a
Perceived Barrier Mean (SD)b
Patient
Embarrassment or anxiety . (1.0)
Fear of pain . (1.1)
Inadequate insurance .0 (1.)
Lack of knowledge about screening tests .8 (1.2)
Lack of knowledge about CRC risk .8 (1.2)
Lack of perceived CRC susceptibility .8 (1.2)
Lack of benefit for CRC screening . (1.2)
Logistical barriers . (1.2)
Low utilization of annual health maintenance visits . (1.2)
Fear of finding cancer . (1.2)
Competing demands . (1.2)
Lack of benefit for CRC treatment . (1.)
Low literacy .2 (1.)
Fatalism .2 (1.2)
Poor patient adherence .2 (1.)
Cultural factors .2 (1.2)
Inability to perform preparation for procedures .1 (1.1)
Family or friends had bad CRC experience 2.9 (1.1)
Language (non- or weak English speaker) 2. (1.2)
Non-US citizenship status 2. (1.)
Colonoscopy complications 2. (1.1)
Barium enema complications 1. (1.1)
Flexible sigmoidoscopy complications 1. (1.0)
Perceived Barrier Mean (SD)b
Provider
Limited accuracy of FOBT .1 (1.)
Lack of time to discuss screening 2. (1.1)
Lack of sigmoidoscopy skills 2.1 (1.8)
Lack of time to arrange screening 2.0 (1.1)
Difficulty counseling about screening 1.8 (1.0)
Complexity of screening options 1. (1.0)
Questions about efficacy of screening 1. (1.0)
System barriers: implementing screening
Lack of screening system reminder 2.8 (1.)
Lack of support staff for follow-up 2. (1.)
Lack of FOBT result tracking system 2. (1.)
Lack of patient educational material 2. (1.)
Inadequate reimbursement for screening 2.0 (1.)
System barriers: obtaining lower endoscopy
Long waits to get lower endoscopy .0 (1.)
Lack of resources for screening procedures 2. (1.)
Difficulty scheduling lower endoscopy 2. (1.)
Lack of resources for diagnostic procedures 2. (1.)
Poor feedback on procedural results 2.2 (1.2)
 
Abbreviations: SD, standard deviation; CRC, colorectal cancer; FOBT, fecal 
occult blood test. 
a Barriers were rated by providers for perceived frequency using a -point 
scale from 1 = “never”/“not” to  = “most”/“very”. 
b A multivariate analysis of variance showed that means differing by ≥0.2 
were significantly different at P < .0 by Fisher’s least significant difference 
method for all barriers except for system barriers, for which means differing 
by ≥0.3 were significant.VOLUME 8: NO. 2
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Table 4. Reasons for Not Undergoing Colorectal Cancer Screening Reported by Adults Aged 50 Years or Older (N = 3,355) in New 
Mexico, Behavioral Risk Factor Surveillance System (BRFSS), 2004a
Reason
Never Had Home 
FOBT, % (95% CI), n = 
1,695
No Home 
FOBT in Previous Year, % 
(95% CI), n = 798
Never Had 
Lower Endoscopy, % (95% 
CI), n = 1,504
No Lower Endoscopy 
in Previous 5 Years, % 
(95% CI), n = 297
Physician never suggested . (.9-9.) . (1.2-9.) .8 (2.9-8.) .9 (2.-0.8)
Physician said not necessary . (.-.) 9.0 (.8-11.9) .0 (2.1-.) .8 (.-9.)
Did test in physician office 1.0 (11.-1.0) . (.9-.) NA NA
No symptoms 0. (28.2-.) 21.9 (18.8-2.2) . (0.-.) . (0.1-.0)
No family history 2. (1.8-.9) 1.1 (0.-2.) . (.-.0) .9 (1.-9.0)
Cost too high or not covered 0.9 (0.-1.) 1.0 (0.-2.0) . (.-.0) .8 (2.9-8.0)
Too young 0. (0.-1.) 0 0.9 (0.-1.) 0
Too old 0.2 (0.1-0.) 1 (0.-.) 0. (0.2-1.) 0
No time 1. (0.9-2.9) 2. (1.-.) 2. (1.-.1) 1. (0.-2.9)
Distasteful 2.2 (1.-.) 1. (0.-2.) .0 (.0-.2) .0 (2.2-.)
Embarrassing 0. (0.-0.9) 0. (0.1-2.) 1. (0.-2.) 0.2 (0.0-1.)
Fear of cancer 0. (0.1-0.9) 0 0.8 (0.-1.) 0
Test painful NA NA 2. (1.-.) .0 (2.2-.1)
Do not know where to get test 0. (0.1-0.) 0.1 (0.0-1.0) 0.1 (0.0-0.9) 0. (0.1-2.)
Do not know how to get test 0.8 (0.-1.) 0.1 (0.0-0.) 0.1 (0.0-0.) 0
Never have routine checkup 2. (1.-.) . (.0-.9) 2. (1.-.) 1.1 (0.-.0)
Some other reason 2.8 (2.0-.9) . (.2-.8) . (2.-.8) . (2.2-8.)
 
Abbreviations: FOBT, fecal occult blood test; CI, confidence interval; NA, not applicable. 
a Values represent weighted population-based estimates for 200 New Mexico BRFSS respondents aged 0 y or older.